Figo Staging System

The Figo Staging system is one of the most common methods for classifying malignant tumors of the female reproductive system. This method was developed by the International Federation of Obstetrics and Gynecology (FIGO) and is used to determine the extent of cancer of the ovary, uterus and cervix.

The Figo system is based on assessing the spread of the tumor within tissues and organs, as well as the presence or absence of metastases in the lymph nodes and other organs. The classification includes four stages, which describe the extent of the tumor's spread and help doctors determine the most effective treatment method.

The first stage (I) describes a tumor that is limited to only one organ. The second stage (II) is characterized by the spread of the tumor to neighboring organs and tissues. The third stage (III) describes the spread of the tumor to distant organs and tissues within the body. Finally, the fourth stage (IV) is characterized by the presence of metastases in other organs and tissues.

The Figo system also includes the use of additional letter symbols that indicate additional factors that influence the prognosis and treatment of cancer. For example, the letter "A" indicates the absence of symptoms, and the letter "B" indicates the presence of symptoms.

The Figo classification system is an important tool for determining the stage of cancer and choosing the most effective treatment method. It also allows doctors to compare treatment results and predict patient survival. In turn, this helps improve treatment outcomes and improve the quality of life of patients with malignant tumors of the female reproductive system.

In conclusion, the Figo system is an important tool for staging ovarian, uterine and cervical cancer. It allows doctors to choose the most effective treatment method and predict patient survival. This helps improve treatment outcomes and improve the quality of life of patients with malignant tumors of the female reproductive system.



The Figo system is a classification developed by the International Federation of Obstetrics and Gynecology (FIGO) to determine the prevalence of malignant tumors of the female genital organs. It is used to assess a woman's health and plan treatment.

The Figo system consists of three levels: I, II and III. Level I is the stage when the tumor is in the area of ​​the ovaries and uterus, level II is when it has spread to the cervix, and level III is when the tumor has spread beyond the uterus.

The Figo classification is used to determine treatment tactics, select surgical methods, and determine survival prognosis. It also helps the doctor determine what additional studies and tests need to be performed to more accurately diagnose the disease.

However, it should be noted that the Figo system is not the only method for assessing the health of women with ovarian, cervical or uterine cancer. It can be supplemented with other diagnostic and treatment methods, which depend on the individual characteristics of each patient.

Overall, the Figo system is an important tool for assessing the prevalence of gynecologic cancer and planning treatment, but it is not the only one. It is important to remember that each case is individual, and for an accurate diagnosis and selection of the correct treatment tactics, many factors must be taken into account.



The Figo system is an effective tool for the diagnosis and classification of malignant neoplasms in women. The Figo system was developed by the International Federation of Gynecologists based on the recommendations of the World Health Organization and the International Agency for Research on Cancer.

The Figo system consists of several categories, each of which corresponds to a certain degree of malignancy of the tumor. Depending on the category, the patient may receive different treatment recommendations and prognosis for recovery.

Category I: The most common category is a tumor smaller than 3 cm and without lymph node metastases. This often means that the tumor has not spread to other parts of the body and can potentially be removed surgically. Majority